Suchergebnisse - "Yalçın-Şahiner, Şafak"

PubPharm (9)

1

Comparison of the immunoassay method with the commercial and in-house LC-MS/MS methods for substance abuse in urine

enthalten in: Turkish journal of biochemistry | 2023

von Avcioglu, G. | Yilmaz, G. | Yalcin Sahiner, S. | +3

2

Association of OPRK1 rs963549 and rs997917 polymorphisms with opioid use disorder and related phenotypes

enthalten in: Pharmacogenomics | 2023

von Özkan-Kotiloğlu, S. | Kaya-Akyüzlü, D. | Yalçın-Şahiner, �. | +1

3

Sublingual buprenorphine/naloxone treatment is not affected by OPRM1 A118G and BDNF Va66Met polymorphisms, but alters the plasma beta-endorphin and BDNF levels in individuals with opioid use disorder

enthalten in: Environmental toxicology and pharmacology | 2022

von Kaya-Akyüzlü, D. | Özkan-Kotiloğlu, S. | Bal, C. | +3

4

Effects of UGT2B7 rs7662029 and rs7439366 polymorphisms on sublingual buprenorphine metabolism in heroin addicts : An improved PCR-RFLP assay for the detection of rs7662029 polymorphism

enthalten in: Environmental toxicology and pharmacology | 2022

von Kaya-Akyüzlü, D. | Özkan-Kotiloğlu, S. | Bal, C. | +3

5

Association of PDYN 68-bp VNTR polymorphism with sublingual buprenorphine/naloxone treatment and with opioid or alcohol use disorder : Effect on craving, depression, anxiety and age onset of first use

enthalten in: European journal of pharmacology | 2022

von Kaya-Akyüzlü, D. | Özkan-Kotiloğlu, S. | Yalçın-Şahiner, �. | +2

6

Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls

enthalten in: Clinical biochemistry | 2021

von Avcioglu, G. | Yilmaz, G. | Yalcin Sahiner, S. | +3

7

DTI-MRI findings in synthetic cannabinoid users

enthalten in: Turkish journal of medical sciences | 2020

von Gökharman, F. | Aydin, S. | Paltun, S. | +3

8

Association of serum brain derived neurotropic factor with duration of drug-naive period and positive-negative symptom scores in drug naive schizophrenia

enthalten in: PloS one | 2017

von Bakirhan, A. | Yalcin Sahiner, S. | Sahiner, I. | +2

9

TNF-related weak inducer of apoptosis (TWEAK) levels in schizophrenia

enthalten in: Psychiatry research | 2015

von Tatlıdil Yaylacı, E. | Yüksel, R. | Ünal, K. | +5

1
[1]